Market Overview

UPDATE: Morgan Stanley Downgrades CIT Group to Equal-Weight on Fewer Catalysts Outstanding

Related CIT
Morgan Stanley: These 2 Banks Are Top M&A Candidates
CIT Serves As Joint Lead Arranger In $225M Acquisition Financing To Clearlake Capital Group

Morgan Stanley downgraded CIT Group (NYSE: CIT) from Overweight to Equal-weight and maintained a $46.00 price target.

Morgan Stanley said, "Risk-reward skew looks more balanced; we see fewer NT catalysts to drive CIT meaningfully higher. CIT shares are up 18% from lows post 3Q12 earnings as the company has achieved several key milestones to achieving their long-term targets, most importantly the elimination of more than $15B of high-cost debt and growing deposits to 31% of funding. Next catalysts for the stock include approval of CIT's capital plan, removal of the written agreement, and potential acquisitions (as indicated by mangement)."

CIT Group closed at $42.71 on Wednesday.

Latest Ratings for CIT

DateFirmActionFromTo
Oct 2014MacquarieUpgradesUnderperformNeutral
Aug 2014Credit SuisseMaintainsNeutral
Jul 2014Morgan StanleyUpgradesEqual-weightUnderweight

View More Analyst Ratings for CIT
View the Latest Analyst Ratings

Posted-In: Morgan StanleyAnalyst Color Downgrades Analyst Ratings

 

Related Articles (CIT)

Around the Web, We're Loving...

Get Benzinga's Newsletters